LDDD.US Longduoduo Company Limited
- Market cap
- USD 15.3M
- P/E
- -
- P/B
- 21.75x
- ROE
- -82.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is LDDD.US undervalued?
Graham numberThe Graham number of Longduoduo Company Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Longduoduo Company Limited fundamental analysis
No fundamental analysis for Longduoduo Company Limited yet.
Longduoduo Company Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Longduoduo Company Limited
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, gastrointestinal digestive disorders, and cardiovascular and cerebrovascular diseases through third-party healthcare s…
Full company profileLongduoduo Company Limited financial statements
Longduoduo Company Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 414K | 3.24M | 3.82M | 7.39M | 4.26M | 1.82M |
| Gross Profit | 320K | 2.23M | 3.23M | 7.22M | 4.17M | 1.81M |
| Operating Income | -378K | -7.56M | 29.2K | 2.03M | 553K | -633K |
| EBITDA | -376K | -7.50M | 99.1K | 1.99M | 852K | -523K |
| Net Income | -329K | -7.52M | -39.1K | 1.26M | 460K | -579K |
| EPS | 0.00 | -0.25 | 0.00 | 0.04 | 0.02 | -0.02 |
| Balance Sheet | ||||||
| Total Assets | 514K | 611K | 1.48M | 2.06M | 2.13M | 2.06M |
| Total Liabilities | 899K | 1.63M | 2.05M | 1.28M | 830K | 1.31M |
| Shareholders' Equity | -334K | -929K | -542K | 703K | 1.18M | 704K |
| Cash & Short-term Investments | 273K | 357K | 1.14M | 1.40M | 1.64M | 1.59M |
| Total Debt | 91.2K | 181K | 13.5K | 35.9K | 18.6K | 49.1K |
| Cash Flow | ||||||
| Operating Cash Flow | 350K | 28.6K | 965K | 582K | 277K | -163K |
| Capital Expenditure | 69.6K | 112K | 126K | 305K | 59.4K | 30.6K |
| Free Cash Flow | 281K | -83.3K | 839K | 277K | 218K | -194K |
| Ratios | ||||||
| ROE | - | - | - | 178.7% | 38.9% | -82.2% |
| ROA | -64.0% | -1,231.0% | -2.6% | 60.8% | 21.7% | -28.0% |
| Net Profit Margin | -79.4% | -232.2% | -1.0% | 17.0% | 10.8% | -31.8% |
| Debt to Equity | - | - | - | 0.05x | 0.02x | 0.07x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Longduoduo Company Limited dividends
Longduoduo Company Limited has not paid dividends in the last 6 fiscal years.
Last stock split: 1:10 on Sep 27, 2023.
Who owns Longduoduo Company Limited
- Insiders 67.67%
- Institutions 0.00%
- Public & others 32.34%
- Shares outstanding 30.0M
- Free float 9.71M
Longduoduo Company Limited company profile
- Company name
- Longduoduo Company Limited
- Ticker
- LDDD.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 51
- Fiscal year end
- June
- Address
- G3-5-8016 Shui?an Town, Hohhot, China, 010000
- Phone
- 86 47 2510 4980
- Website
- longduoduo.net
About Longduoduo Company Limited
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, gastrointestinal digestive disorders, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; and relaxation therapy services. Longduoduo Company Limited was founded in 2020 and is headquartered in Hohhot, China.
Longduoduo Company Limited management
3- Mr. Huibo XuPresident & Chairman · born 1982
- Ms. Hongxiao ZhouCEO, Secretary & Director · born 1976
- Ms. Liping KangChief Financial Officer · born 1983